Renin-angiotensin system inhibitors in proteinuric chronic kidney disease

Sheldon Hirsch

Renin-angiotensin system inhibitors in proteinuric chronic kidney disease

Compr Ther. 2009 Summer;35(2):91-5.

Author

Sheldon Hirsch¹

Affiliation

¹ Department of Nephrology, Mercy Hospital, Chicago, IL, USA. [email protected]

PMID: 19618757

Abstract

Renin-angiotensin inhibitors are effective in slowing the progression of chronic proteinuric kidney disease. These medicines should be used in preference to anti-hypertensives that do not provide renoprotection.

Publication types

Review

MeSH terms

Angiotensin II Type 2 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Angiotensins / antagonists & inhibitors*
Antihypertensive Agents / adverse effects
Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use*
Humans
Kidney Failure, Chronic / drug therapy
Kidney Failure, Chronic / prevention & control
Mineralocorticoid Receptor Antagonists / pharmacology
Mineralocorticoid Receptor Antagonists / therapeutic use
Proteinuria / drug therapy*
Renal Insufficiency, Chronic / drug therapy*
Renal Insufficiency, Chronic / urine
Renin / antagonists & inhibitors*
Renin-Angiotensin System

Substances

Angiotensin II Type 2 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Angiotensins
Antihypertensive Agents
Mineralocorticoid Receptor Antagonists
Renin